GO:0005811 lipid droplet: Components, Assembly and Research Methods, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0005811 lipid droplet is an intracellular non-membrane-bounded organelle with a neutral lipid core surrounded by a phospholipid monolayer.
• Lipid droplets are dynamic organelles central to energy storage, lipid homeostasis, and cellular stress responses.
• Proteins such as the perilipin family (PLIN1-5), DGAT1/2, and CIDEC coat lipid droplets and regulate their formation and lipolysis.
• Lipid droplets interact with mitochondria and other organelles, influencing fatty acid oxidation and metabolic signaling.
• Dysregulation of lipid droplets is linked to metabolic diseases, cancer, neurodegeneration, and cardiomyopathy.
• CRISPR-based knockout, knock-in, and overexpression models enable functional dissection of lipid droplet biology.
Description
Lipid droplets (LDs) are ubiquitous intracellular organelles that serve as the primary storage sites for neutral lipids, such as triglycerides and cholesterol esters. Unlike most organelles, LDs are not bounded by a bilayer membrane; instead, they consist of a hydrophobic lipid core encased by a phospholipid monolayer with embedded proteins. This unique architecture allows LDs to rapidly expand and shrink in response to metabolic demands, making them key players in energy homeostasis and lipid signaling. Researchers study LDs to understand fundamental processes like lipid metabolism, membrane trafficking, and cellular stress responses, as well as their contributions to diseases ranging from obesity and diabetes to cancer and neurodegeneration. The Gene Ontology term GO:0005811 provides a standardized annotation for this organelle, facilitating genomic and proteomic analyses.
lipid droplet At A Glance
| GO ID | GO:0005811 |
|---|---|
| GO term | lipid droplet |
| Ontology | cellular_component |
| Synonym | adiposome, lipid body, lipid particle |
| Major function | Storage of neutral lipids, regulation of lipid homeostasis, and participation in cellular stress responses |
| Structure | Hydrophobic lipid core surrounded by a phospholipid monolayer with associated proteins |
| Associated proteins | Perilipins (PLIN1-5), DGAT1/2, CIDEC, and many others |
| Disease relevance | Metabolic disorders, cancer, neurodegeneration, cardiomyopathy |
What Is GO:0005811?
GO:0005811 lipid droplet is defined as an intracellular non-membrane-bounded organelle comprising a matrix of coalesced lipids surrounded by a phospholipid monolayer. It may include associated proteins. This definition captures the essential structural features: a neutral lipid core, a single phospholipid layer, and the potential for protein decoration, which together distinguish LDs from other organelles.
Why Is lipid droplet Important in Cell Biology?
Lipid droplets are not merely passive fat depots; they are dynamic organelles that integrate lipid metabolism with cellular signaling, energy balance, and stress responses. Their dysfunction is implicated in a wide range of human diseases, including obesity, type 2 diabetes, non-alcoholic fatty liver disease, cancer, and neurodegenerative conditions. Understanding LD biology at the molecular level is therefore critical for developing therapeutic strategies targeting lipid metabolism.
• Central to energy storage and mobilization in adipocytes and other cell types.
• Regulate lipid homeostasis and prevent lipotoxicity by sequestering excess fatty acids.
• Serve as platforms for protein interactions and signaling events.
• Involved in the pathogenesis of metabolic diseases such as obesity and diabetes.
• Linked to cancer progression through altered lipid metabolism and LD accumulation.
• Implicated in neurodegeneration and neuroinflammation, including microglial lipid droplet accumulation.
• Associated with cardiomyopathy and heart failure.
• Provide targets for therapeutic intervention in lipid-related disorders.
Core Biology of the Lipid Droplet
Biogenesis and Nucleation
In simple terms: Lipid droplets are born when fats accumulate within the cell and bud off from the endoplasmic reticulum.
Lipid droplet biogenesis begins with the synthesis of neutral lipids, such as triglycerides and sterol esters, within the endoplasmic reticulum (ER) membrane. These lipids coalesce into lens-like structures that eventually bud off to form nascent LDs. The process is driven by enzymes like DGAT1 and DGAT2, which catalyze the final step of triglyceride synthesis. Proteins such as seipin and perilipins are recruited early and stabilize the growing droplet. The exact mechanisms of nucleation and budding are still under investigation, but they are critical for LD formation and function.
Growth and Maturation
In simple terms: Once formed, lipid droplets can grow larger by adding more fats and proteins.
Nascent LDs can expand through the addition of neutral lipids, either by local synthesis or by transfer from other membranes. This growth is accompanied by the recruitment of specific proteins, including members of the perilipin family (PLIN1-5), which coat the LD surface and regulate access of lipases. The phospholipid monolayer also expands, and its composition can change to accommodate the increasing surface area. Maturation involves interactions with other organelles, such as mitochondria and the ER, which facilitate lipid exchange and signaling.
Lipolysis and Turnover
In simple terms: When the cell needs energy, lipid droplets are broken down to release fatty acids.
Lipolysis is the process by which neutral lipids stored in LDs are hydrolyzed to release free fatty acids and glycerol. This process is tightly regulated by lipases, including adipose triglyceride lipase (ATGL) and hormone-sensitive lipase (HSL), which are recruited to the LD surface by perilipins. The released fatty acids can be used for energy production via beta-oxidation in mitochondria or for other cellular needs. Defects in lipolysis lead to excessive LD accumulation and metabolic dysfunction.
Interactions with Other Organelles
In simple terms: Lipid droplets communicate with other parts of the cell to coordinate metabolism.
LDs form physical contacts with mitochondria, ER, and peroxisomes, facilitating the transfer of lipids and metabolites. For example, LD-mitochondria contacts are important for fatty acid oxidation, and proteins like PFKL can promote this tethering to enhance beta-oxidation. These interactions are dynamic and respond to cellular energy status, influencing processes such as autophagy and apoptosis. Disruption of organelle contacts contributes to metabolic diseases.
Key Genes Involved in GO:0005811 lipid droplet
The following genes and proteins are key players in lipid droplet biology, as supported by the cited literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| PLIN1 | Perilipin 1; coats lipid droplets in adipocytes, regulates lipolysis | Mutations linked to lipodystrophy and metabolic disorders |
| PLIN2 | Perilipin 2; ubiquitous LD protein, protects LDs from lipolysis | Involved in hepatic steatosis and cancer |
| PLIN3 | Perilipin 3; involved in LD formation and trafficking | Role in lipid storage and membrane dynamics |
| PLIN4 | Perilipin 4; expressed in adipose tissue and muscle | Associated with lipid metabolism and insulin sensitivity |
| PLIN5 | Perilipin 5; links LDs to mitochondria for oxidation | Key regulator of fatty acid oxidation in oxidative tissues |
| DGAT1 | Diacylglycerol O-acyltransferase 1; synthesizes triglycerides | Target for obesity and insulin resistance |
| DGAT2 | Diacylglycerol O-acyltransferase 2; synthesizes triglycerides | Critical for LD formation and hepatic lipid metabolism |
| CIDEC | Cell death-inducing DFFA-like effector c; promotes LD fusion and growth | Mutations cause familial partial lipodystrophy |
| ATGL | Adipose triglyceride lipase; initiates lipolysis | Defects cause neutral lipid storage disease |
| HSL | Hormone-sensitive lipase; hydrolyzes diacylglycerols | Regulates lipolysis in adipocytes |
| PFKL | Phosphofructokinase, liver type; promotes LD-mitochondria tethering | Enhances beta-oxidation and tumor cell proliferation |
| SEIPIN | Seipin; involved in LD biogenesis at the ER | Mutations cause Berardinelli-Seip congenital lipodystrophy |
| FIT2 | Fat storage-inducing transmembrane protein 2; promotes LD formation | Regulates lipid storage and ER homeostasis |
| Rab18 | Small GTPase; regulates LD dynamics and ER contact | Involved in lipid trafficking and viral replication |
| CCTα | CCTalpha; regulates phosphatidylcholine synthesis for LD surface | Important for LD expansion and phospholipid monolayer |
| LDAF1 | Lipid droplet assembly factor 1; assists in LD formation | Identified as a key factor in LD biogenesis |
| UBXD8 | UBX domain-containing protein 8; involved in LD turnover | Links LDs to ER-associated degradation |
How Is lipid droplet Regulated?
Lipid droplet dynamics are regulated by multiple signaling pathways, including nutrient-sensing pathways such as mTOR, which promotes lipid synthesis and LD growth under nutrient-rich conditions. Conversely, energy stress activates AMPK, which inhibits lipid synthesis and stimulates lipolysis. Hormonal signals, such as insulin and catecholamines, also modulate LD metabolism through phosphorylation of perilipins and lipases. Additionally, the integrated stress response (ISR) can influence LD formation and composition. These regulatory mechanisms ensure that LD number, size, and composition adapt to cellular needs.
lipid droplet and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| PLIN1 | Lipodystrophy, obesity | Knockout mouse, adipocyte-specific KO |
| CIDEC | Familial partial lipodystrophy | Knock-in of patient mutations in cell lines |
| PFKL | Cancer proliferation | Knockout in cancer cell lines, xenograft models |
| PLIN5 | Cardiomyopathy | Cardiomyocyte-specific knockout |
| PLIN2 | Hepatic steatosis | Liver-specific knockout mice |
Metabolic Disorders
Dysregulation of lipid droplets is a hallmark of metabolic diseases such as obesity, type 2 diabetes, and non-alcoholic fatty liver disease (NAFLD). Excessive LD accumulation in adipocytes and hepatocytes leads to insulin resistance and lipotoxicity. Mutations in genes encoding LD-associated proteins, such as PLIN1 and CIDEC, cause lipodystrophies and severe metabolic complications. Targeting LD biology is therefore a promising therapeutic strategy for these conditions.
Cancer
Many cancer cells exhibit increased lipid droplet accumulation to support rapid proliferation and survival under stress. LDs provide energy and building blocks for membrane synthesis and protect against oxidative stress. In some tumors, LD-mitochondria tethering mediated by PFKL enhances beta-oxidation and promotes tumor growth. Thus, LD-associated proteins are potential targets for cancer therapy.
Neurodegeneration and Neuroinflammation
Lipid droplets accumulate in microglia and astrocytes in neurodegenerative conditions, where they may modulate inflammatory responses. In Alzheimer's disease and other tauopathies, LD accumulation in glia is associated with disease progression. Understanding the role of LDs in the brain may reveal new therapeutic avenues for neuroinflammation.
Cardiomyopathy
In the heart, lipid droplets are essential for energy production, but excessive accumulation leads to lipotoxic cardiomyopathy. Mutations in LD-associated proteins, such as PLIN5, have been linked to heart failure. Studying LD dynamics in cardiomyocytes is critical for developing treatments for heart disease.
From lipid droplet-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X regulate LD size? | CRISPR knockout in HeLa or HepG2 cells followed by imaging |
| Does mutation Y affect LD-mitochondria contact? | Point mutation knock-in in U2OS cells |
| Does overexpression of gene Z increase LD accumulation? | Doxycycline-inducible overexpression in 3T3-L1 adipocytes |
| What proteins localize to LDs? | Tagged knock-in (e.g., GFP) of candidate genes |
| Does gene X affect lipolysis? | Knockout in primary adipocytes and lipolysis assays |
| Can we screen for novel LD regulators? | Genome-wide CRISPR knockout library in lipid-loaded cells |
How to Study the lipid droplet Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Fluorescence microscopy | LD number, size, and localization | Visualizing LD dynamics in live cells |
| Electron microscopy | Ultrastructure of LDs | Detailed morphological analysis |
| Proteomics | LD-associated proteins | Identifying novel LD proteins |
| Lipidomics | Lipid composition of LDs | Quantifying changes in lipid species |
| CRISPR knockout screens | Genes affecting LD accumulation | High-throughput discovery of regulators |
| Lipolysis assay | Free fatty acid and glycerol release | Measuring LD breakdown |
| Triglyceride assay | Triglyceride content | Quantifying LD lipid storage |
Imaging Techniques
Fluorescence microscopy with lipid-specific dyes (e.g., BODIPY 493/503, Oil Red O) is widely used to visualize LDs and quantify their number and size. Live-cell imaging allows tracking of LD dynamics and interactions with other organelles. Electron microscopy provides ultrastructural details of LD morphology.
Proteomics and Lipidomics
Proteomic analysis of isolated LDs identifies associated proteins and their post-translational modifications. Lipidomics quantifies the lipid composition of LDs and changes under different conditions. These approaches are essential for understanding LD function and regulation.
Genetic Screens
CRISPR-based knockout screens have been used to identify genes that regulate LD accumulation and turnover. Such screens can be performed in various cell types and under different metabolic conditions. The results provide unbiased insights into LD biology.
Biochemical Assays
Lipolysis assays measure the release of free fatty acids and glycerol from cells, reflecting LD breakdown. Triglyceride quantification kits assess LD lipid content. These assays are used to study the effects of genetic perturbations on LD metabolism.
How CRISPR Can Be Used to Study GO:0005811 lipid droplet
Knockout
CRISPR knockout is used to delete genes encoding LD-associated proteins to study their function. For example, knocking out PLIN1 in adipocytes leads to increased basal lipolysis. Knockout of DGAT1 or DGAT2 reduces LD formation. These models help establish causality between genes and LD phenotypes.
Point Mutation
Point mutations can be introduced to model disease-associated variants in LD proteins. For instance, knock-in of PLIN1 mutations found in lipodystrophy patients can reveal how these mutations affect LD stability and lipolysis. Such models are valuable for understanding molecular mechanisms of disease.
Knock-in
Knock-in of tagged versions of LD proteins (e.g., GFP-PLIN2) allows real-time tracking of LD dynamics and protein localization. This approach is useful for studying LD biogenesis and interactions with other organelles.
Overexpression
Overexpression of genes like CIDEC or PLIN5 increases LD size and number, providing insights into their roles in lipid storage and oxidation. Inducible overexpression systems allow controlled experiments to study dose-dependent effects.
How EDITGENE Supports lipid droplet Research
Researchers studying lipid droplet-related genes often need to determine whether a candidate gene is causally involved in LD formation, growth, or turnover. EDITGENE provides a comprehensive suite of CRISPR services to enable precise genetic manipulation and functional studies.
Contact EDITGENE today to design your custom CRISPR model for lipid droplet research.
Frequently Asked Questions About lipid droplet
What is a lipid droplet (GO:0005811)?
A lipid droplet is an intracellular non-membrane-bounded organelle composed of a neutral lipid core surrounded by a phospholipid monolayer, often with associated proteins.
What genes are involved in lipid droplet formation?
Key genes include PLIN1-5, DGAT1, DGAT2, CIDEC, SEIPIN, and FIT2, among others.
What is the function of lipid droplets?
They store neutral lipids for energy, regulate lipid homeostasis, and participate in cellular stress responses and signaling.
How are lipid droplets studied?
Common methods include fluorescence microscopy, proteomics, lipidomics, and CRISPR screens.
What diseases are associated with lipid droplets?
Metabolic disorders, cancer, neurodegeneration, and cardiomyopathy are linked to LD dysfunction.
What proteins coat lipid droplets?
The perilipin family (PLIN1-5) are major coat proteins, along with others like CIDEC and DGAT enzymes.
How do lipid droplets interact with mitochondria?
They form contact sites that facilitate fatty acid transfer and beta-oxidation, regulated by proteins like PFKL.
Can CRISPR be used to study lipid droplets?
Yes, CRISPR knockout, knock-in, and overexpression models are widely used to dissect LD gene function.
What is the role of lipid droplets in cancer?
They support cancer cell proliferation by providing energy and protecting against oxidative stress.
How does EDITGENE support lipid droplet research?
EDITGENE provides CRISPR cell model generation, library screening, and bioinformatics services tailored to LD biology.
Conclusion
Lipid droplets are dynamic organelles essential for lipid storage and cellular homeostasis, with critical roles in health and disease. The Gene Ontology term GO:0005811 provides a standardized framework for annotating and studying these organelles. Advances in CRISPR-based models and imaging technologies continue to unravel the complex biology of lipid droplets, offering new opportunities for therapeutic intervention.
References
- 1. Zadoorian A et al.. 2023. Lipid droplet biogenesis and functions in health and disease.. Nat Rev Endocrinol 19(8):443-459 PMID: 37221402
- 2. Meng Y et al.. 2024. Glycolytic enzyme PFKL governs lipolysis by promoting lipid droplet-mitochondria tethering to enhance β-oxidation and tumor cell proliferation.. Nat Metab 6(6):1092-1107 PMID: 38773347
- 3. Fan H et al.. 2024. Lipid Droplet-Mitochondria Contacts in Health and Disease.. Int J Mol Sci 25(13) PMID: 38999988
- 4. Thiam AR et al.. 2021. Lipid Droplet Nucleation.. Trends Cell Biol 31(2):108-118 PMID: 33293168
- 5. Olzmann JA et al.. 2019. Dynamics and functions of lipid droplets.. Nat Rev Mol Cell Biol 20(3):137-155 PMID: 30523332
- 6. Sztalryd C et al.. 2017. The perilipin family of lipid droplet proteins: Gatekeepers of intracellular lipolysis.. Biochim Biophys Acta Mol Cell Biol Lipids 1862(10 Pt B):1221-1232 PMID: 28754637
- 7. Li Y et al.. 2025. Lipid droplet accumulation in microglia and their potential roles.. Lipids Health Dis 24(1):215 PMID: 40514678
- 8. Huang W et al.. 2022. Lipid Droplet-Associated Proteins in Cardiomyopathy.. Ann Nutr Metab 78(1):1-13 PMID: 34856540
